The availability of generic drugs is expected to have a positive impact in Canada, including potential cost savings for ...
The justices are set to hear Hikma v. Amarin, a battle over drug patents that could raise costs for patients and change the ...
Pfizer’s Vyndamax will be free from generics competition until 2031 in a boost to the company’s revenue streams.
Money Digest on MSN
Why are generic medications so cheap and where are they made?
If you've had a prescription lately, chances are good it was part of the 91% of U.S. drugs that are considered generic. So, ...
Health Canada approved on Tuesday the first generic version of Danish drugmaker Novo Nordisk's Ozempic drug.
Pfizer inking the last of three settlements to postpone copycats to its transthyretin amyloid cardiomyopathy (ATTR-CM) med ...
By Bhanvi Satija and Marleen Kaesebier LONDON, April 28 (Reuters) - Novartis posted first-quarter core operating profit and ...
The entry of Dr Reddy's generic is triggering a price battle among pharmaceutical companies worldwide.
Hikma Pharmaceuticals USA v Amarin Pharma presents a complex dispute between Amarin, the manufacturer of Vascepa, a ...
Amneal leans on generics stability, biosimilar launches, and Crexont growth as 2026 guidance points to higher EBITDA and EPS despite Specialty headwinds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results